Dennis L. Cooper, MD

Articles by Dennis L. Cooper, MD

CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability

ByMendel Goldfinger, MD,Nishi Shah, MD,Dennis L. Cooper, MD

March 22nd 2023

Although the first FDA approval for CAR T-cell therapy in multiple myeloma was 2 years ago, unfortunately, the treatment remains out of reach for too many patients.

Latest Updated Articles

CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability
March 22nd 2023

Dennis L. Cooper, MD

Articles by Dennis L. Cooper, MD

CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability

Latest Updated Articles

Trending on OncLive

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis

ESAONA Data Support Asandeutertinib as a Frontline Option in EGFR+ NSCLC With Brain Metastases